Today: 15 March 2026
Subscribe
Browse Category

NSE:DRREDDY 24 December 2025 - 22 January 2026

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
··
India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags

India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags

The Sensex fell 0.30% to 83,627.69 and the Nifty 50 slipped 0.22% after a volatile session Tuesday, with Reliance and L&T among top drags. ONGC and Tech Mahindra led gainers. Foreign investors have sold $1.72 billion in Indian stocks so far in January. The rupee closed at 90.19 per dollar, slightly weaker, as the market eyed India-U.S. trade signals and upcoming earnings.
13 January 2026
·········
Top Stocks to Buy Today in India: ITC, Tata Steel, Dr Reddy’s, Coal India, Ajanta Pharma and More (24 December 2025)

Top Stocks to Buy Today in India: ITC, Tata Steel, Dr Reddy’s, Coal India, Ajanta Pharma and More (24 December 2025)

Indian equities slipped into the red by late afternoon Wednesday, with the Nifty 50 near 26,200 and the Sensex around 85,600 as IT and pharma stocks dragged. Early gains from strong US growth data faded amid cautious trading and thin holiday volumes. RBI’s planned liquidity injection and US visa policy changes weighed on sentiment. Technical analysts flagged Nifty support at 26,050 and resistance near 26,300.
24 December 2025
·····

Stock Market Today

  • Constellation Software Reports Revenue Growth but Net Income Slumps; Shares Drop 14.8%
    March 15, 2026, 4:01 AM EDT. Constellation Software Inc. reported 2025 full-year results with revenue rising 15% to $11.62 billion, but net income fell 30% to $512 million. Earnings per share declined amid margin pressures and one-off items. Despite weaker profits, the company declared a $1.00 per share dividend, reflecting confidence in cash flow. Shares dropped 14.8% following these mixed signals, highlighting investor concerns about profitability sustainability. Valuation debates continue with wide fair value estimates ranging from CA$3,332.98 to CA$7,927 per share. The focus now shifts to management's ability to convert top-line growth into consistent earnings while managing high leverage and premium earnings multiples. Investors weigh cautious optimism against margin risks in Constellation Software's evolving investment case.
Go toTop